Table 5.
Summary of Clinically Significant Caregiver Changes in Primary Outcome Measure for Caregivers by Treatment Group Between Baseline and 12-Month Follow-up
| Dual target, n = 57 |
Caregiver only, n = 56 |
Difference |
Control, n= 60 |
Differences |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diff in net impr dual target vs. caregiver-only Δnb |
Diff in net impr dual target vs. controlb |
Diff in net impr caregiver-only vs. controlb |
||||||||||
| Outcome | Improved n (%) |
Got worse n (%) |
Net impra n (%) |
Improved | Got Worse | Net impra n (%) |
Δ%; Δn (95% CI); Δ% (95% CI) |
Improved n (%) |
Got worse n (%) |
Net impra n (%) |
Δn (Δ%); Δn (95% CI); Δ% (95% CI) |
Δn (Δ%); Δn (95% CI); Δ% (95% CI) |
| CESD | 23 (40.4) | 8 (14.0) | 15 (26.4) | 13 (23.2) | 17 (30.4) | −4 (−7.2) | 19 (33.6); (3 to 33); (6.5 to 57.1) | 17 (28.3) | 15 (25.0) | 2 (3.3) | 13 (25.1); (−2 to 28); (−3 to 48.7) | −6 (−10.5); (−21 to 9); (−35.7 to 16.1) |
| Burden | 30 (52.6) | 9 (15.8) | 21 (36.8) | 20 (35.7) | 17 (30.4) | 3 (5.3) | 18 (31.5); (0 to 35); (1.9 to 61.6) | 19 (31.7) | 15 (25.0) | 4 (6.7) | 17 (30.1); (0 to 33); (2.3 to 58.7) | −1 (−1.4); (−17 to 13); (−28.3 to 24.7) |
| Self-care | 16 (28.1) | 20 (35.1) | −4 (−7.0) | 18 (32.1) | 13 (23.2) | 5 (8.9) | −9 (−15.9); (−26 to 7); (−43.5 to 13.2) | 12 (20.0) | 21 (35.0) | −9 (−15.0) | 5 (8.0); (−12 to 21); (−20.3 to 36.5) | 14 (23.9); (−2 to 29); (−2.7 to 51.7) |
| Health symptoms | 31 (54.4) | 7 (12.3) | 24 (42.1) | 19 (33.9) | 15 (26.8) | 4 (7.1) | 20 (35.0); (2 to 33); (7.2 to 62.7) | 20 (33.3) | 15 (25.0) | 5 (8.3) | 19 (35.8)*; (2 to 35); (7.0 to 62.5) | −1 (−1.2); (−17 to 15); (−26.9 to 28.7) |
| Sat with support | 20 (35.1) | 14 (24.6) | 6 (10.5) | 19 (33.9) | 10 (17.9) | 9 (16.0) | −3 (−5.5); (−19 to 12); (−31.3 to 21.9) | 13 (21.7) | 17 (28.5) | −4 (−6.8) | 10 (17.3); (−6 to 25); (−9.1 to 43.9) | 13 (22.8); (−3 to 27); (−3.1 to 48.3) |
| Soc net density | 16 (28.1) | 17 (29.8) | −1 (−1.7) | 13 (23.2) | 14 (25.0) | −1 (−1.8) | 0 (0.1); (−22 to 5); (−46.2 to 11.3) | 10 (16.7) | 22 (36.7) | −12 (−20.0) | 11 (18.3); (−5 to 26); (−7.6 to 44.4) | 11 (18.2); (−4 to 26); (−5.8 to 43.8) |
Note. Statistically significant effects are in bold. CESD = Center for Epidemiologic Studies Depression Scale; Sat with support = satisfaction with social support; Soc net density = social network density; CI = confidence interval. Clinically significant improvement and worsening was defined as an unadjusted standardized change of ± 0.5 SD or more from baseline to follow-up.
a
Net impr = participants who improved − participants who worsened.
b
Diff in net impr = net improvement in intervention group − net improvement in comparison group. Δn = difference in number; Δ% = difference in percentage.